Authored By: Sarah
30 Dec 2024

Latest News- Artificial Intelligence In Drug Discovery Market: Cloud-based is expected to lead the Deployment segment during 2025-2029

The Artificial Intelligence In Drug Discovery Market is being driven by Availability of funding

The Artificial Intelligence In Drug Discovery Market is expected to grow at a CAGR of 25.7% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 4318.4 million. The global artificial intelligence (AI) market in drug discovery is experiencing a noteworthy trend towards strategic partnerships. These collaborations are essential for pharmaceutical companies to expedite the development of innovative therapeutics by utilizing advanced AI technologies. For instance, in September 2024, Insilico Medicine, a clinical-stage biotechnology firm specializing in generative AI, announced a strategic partnership with Inimmune. This collaboration aims to leverage Insilico's proprietary AI technology, Chemistry42, to accelerate the discovery and development of next-generation immunotherapeutics. Initially, Inimmune will utilize Chemistry42 to tackle specific challenges within their drug discovery pipeline. This alliance underscores the importance of AI in addressing complex drug discovery challenges and enhancing overall efficiency within the industry. 

Get more information on Artificial Intelligence In Drug Discovery Market by requesting a sample report

 

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on Deployment (Cloud-based, On-premises) Therapeutic Area (Oncology, Infectious diseases, Neurology, Metabolic diseases, Others) Geography (North America, Europe, APAC, South America, Middle East and Africa). 

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

  • Availability of funding
  • Government initiatives
  • Expansion of biotechnology sector

Benefits of Buying Global Artificial Intelligence In Drug Discovery Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Key Features in Artificial Intelligence In Drug Discovery Market Research Report

  • Comprehensive Market Analysis
  • In-Depth Competitive Landscape
  • Future Market Trends
  • Detailed Market Segmentation.
  • Expert Analysis, and more...

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

Artificial Intelligence (AI) is revolutionizing the drug discovery industry by optimizing various aspects, including drug structure and clinical trials, personalized medicine, disease prediction, digital health, and drug delivery. AI applications extend to drug resistance, safety, disease association, hit compounds, repurposing, biomarker discovery, gene data, and drug discovery platforms. Precision medicine, safety monitoring, and healthcare innovation are also significantly impacted. Biotechnology, pharmaceutical innovation, medical diagnostics, and regulatory compliance are further areas of application. AI is used for target identification, regulatory certification, and professional standards in drug design. Healthcare, biopharma, and medical device industries are benefiting from AI for drug development, efficacy testing, and regulation.

Market Research Overview

In the realm of business and healthcare, Artificial Intelligence (AI) is revolutionizing drug discovery, particularly in the context of chronic diseases. The AI in Drug Discovery market falls under the application software sector of the IT industry. This market comprises organizations specializing in creating AI-driven solutions for drug development, clinical trials, and disease event prediction. Technavio, a leading market research firm, calculates the size of this market based on the consolidated revenue of these companies, encompassing cloud-based software solutions. This sector's growth is driven by the potential to expedite drug development processes and improve patient outcomes.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.


Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!

Safe and Secure SSL Encrypted

Technavio

  • 2500 USD

[5 reports/month/user]

  • 5000 USD

close
  • Basic Plan [5000 USD/Year]:

    Single User
    Download 5 Reports/Month
    View 100 Reports/Month
    Add upto 3 Users at 625 USD/user

  • Teams Plan [7500 USD/Year]:

    5 User
    Download 5 Reports/Month/User
    View 100 Reports/Month/User
    Add upto 30 Users at 500 USD/user

*You can upgrade to Teams plan at Subscription page

close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization).
    Complimentary Customization Included

*For Enterprise license, go to checkout page

Technavio Get the report (PDF) sent to your email within minutes.